SELLAS annual meeting results: directors re-elected, ESPP amendment approved

SELLAS Life Sciences Group, Inc.

Re-elected Class III directors Stergiou (36.4M for) and Varian (36.7M for); broker non-votes 17.8M.
Ratified Baker Tilly as auditor for FY2025: 56.9M for, 3.4M against, 1.0M abstain.
Approved ESPP amendment increasing shares by 800,000: 28.8M for, 14.0M against.
Non-binding advisory vote on executive compensation passed: 29.6M for, 12.8M against.
Recommended annual frequency for future say-on-pay votes (34.8M for 1 year).

item 5.07

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.